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Campylobacter jejuni is a leading cause of foodborne
illness in industrialized countries. This pathogen ex-
hibits significant strain-to-strain variability, which re-
sults in differences in virulence potential and clinical
presentations. Here, we report that acquisition of the
capacity to utilize specific nutrients enhanced the
ability of a highly pathogenic strain of C. jejuni to col-
onize specific tissues. The acquisition of a gene en-
coding a g-glutamyltranspeptidase enabled this
strain to utilize glutamine and glutathione and en-
hanced its ability to colonize the intestine. Further-
more, the acquisition of a DNA segment, which
added a sec-dependent secretion signal to an other-
wise cytoplasmic asparaginase, allowed this patho-
gen to utilize asparagine and to more efficiently col-
onize the liver. Our results reveal that subtle genetic
changes in a bacterial pathogen result in significant
changes in its ability to colonize specific tissues. In
addition, these studies revealed remarkably specific
nutritional requirements for a pathogen to effectively
colonize different tissues.
INTRODUCTION
Campylobacter jejuni, a representative of the diverse group of
3-proteobacteria, is the leading cause of foodborne diarrhea in
industrialized nations (Allos, 2001). Although enteritis resulting
from C. jejuni infections is usually self-limiting, more than 10%
of untreated patients may suffer prolonged severe illness
(Blaser, 1997). Furthermore, a number of convalescent patients
develop a neurological complication known as Guillain-Barre´
Syndrome (Nachamkin, 2002). Despite its public health impor-
tance, the molecular mechanisms of C. jejuni pathogenesis
that lead to such a variety of clinical presentations are very
poorly understood. It is well established that much of the genetic
diversity among different isolates of C. jejuni is found in putative
virulence factors, in particular among surface structures (Gilbert
et al., 2002; Dorrell et al., 2001; Karlyshev et al., 2005; Logan
et al., 2002; Pearson et al., 2003; Taboada et al., 2004) that
are thought to be under direct evolutionary pressure from the
host’s immune response (van der Woude and Baumler, 2004).
However, much less is known about bacterial diversity in basicCell Hostmetabolic traits that may also be subject to host selection and
may have a major influence in pathogenicity. Furthermore, it is
not known how metabolic differences may affect the ability of
pathogenic bacteria to colonize different tissues, since very little
is known about specific requirements for growth and persis-
tence in these environments.
C. jejuni cannot utilize sugars as a carbon source because it
lacks the glycolytic enzyme phosphofructokinase (Parkhill
et al., 2000; Velayudhan and Kelly, 2002). Consequently, the
growth of C. jejuni is thought to depend mainly on the availability
of free amino and keto acids scavenged from the host or from
the intestinal microbial flora (Lee and Newell, 2006). Studies
have shown that serine, aspartate, glutamate, and proline are
preferentially used by C. jejuni as nutritional substrates in vitro
(Leach et al., 1997; Elharrif and Megraud, 1986; Leon-Kempis
Mdel et al., 2006; Velayudhan et al., 2004), and that serine
catabolism as well as amino acid transporters are required for
colonization of the intestinal tract (Velayudhan et al., 2004;
Hendrixson and DiRita, 2004). Here we report that different
strains of C. jejuni exhibit considerable diversity in their ability
to utilize amino acids. We found that subtle genetic changes
in a bacterial pathogen result in significant changes in its ability
to utilize nutrients and colonize specific tissues in an animal
model of infection.
RESULTS
Campylobacter jejuni 81-176 Exhibits Expanded Ability
to Utilize Amino Acids
In an effort to understand pathogenic differences among C. je-
juni strains, we compared the 81-176 strain, shown to be highly
infectious in experimental infections in monkeys (Russell et al.,
1989) and human volunteers (Black et al., 1988), with the refer-
ence NCTC 11168 strain, for their ability to utilize different
amino acids. As recently reported for C. jejuni strain NCTC
11168 (Guccione et al., 2008), C. jejuni 81-176 was able to
grow in the presence of aspartate, glutamate, proline, and ser-
ine (Figure 1). Surprisingly, however, C. jejuni 81-176 was also
able to grow in the presence of glutamine and asparagine,
which did not sustain the growth of the reference strain
NCTC 11168 (Figure 1). These amino acids have not been pre-
viously reported to be substrates that can be utilized for growth
by C. jejuni. These results indicate that C. jejuni 81-176 exhibits
additional metabolic traits, which may enhance its virulence
properties.& Microbe 4, 425–433, November 13, 2008 ª2008 Elsevier Inc. 425
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the Ability to Utilize Glutamine and Glutathione
Since the ability to utilize glutamine was absent from the C. jejuni
NCTC 11168 strain, we hypothesized that genetic determinants
present solely in C. jejuni 81-176 must be responsible for this
metabolic expansion. A C. jejuni 81-176 gene (cju06), which is
absent from the NCTC 11168 strain, encodes a secreted
g-glutamyltranspeptidase (GGT) (Hofreuter et al., 2006). This en-
zyme is identical to the recently reported homolog of C . jejuni
81116 (Barnes et al., 2007), and exhibits high amino acid se-
quence similarity to the GGT of Helicobacter pylori (Chevalier
et al., 1999) (Figure S1). Like its homolog in H. pylori, in C. jejuni
GGT is produced as a 60 kDa proenzyme that is processed upon
periplasmic secretion into an active enzyme consisting of 40 kDa
and 20 kDa subunits (Figure 2A). GGT catalyzes the degradation
of glutathione to glutamate and a cysteinylglycine dipeptide
through a transpeptidation reaction that transfers the g-glutamyl
moiety to amino acids and peptides. In addition, this enzyme can
hydrolyze glutathione and glutamine, releasing free glutamate
(Tate and Meister, 1981). We therefore hypothesized that the hy-
drolytic activity of GGT may lead to the deamination of gluta-
mine, and hence allow its utilization by C. jejuni 81-176 via gluta-
mate, the end product of this reaction. Consistent with this
hypothesis, the isogenic ggt::kan mutant of C. jejuni 81-176
was unable to utilize glutamine for growth in DMEM (Figure 2B).
Although the presence of glutathione in bacteria is well estab-
lished (Fahey et al., 1978), analysis of the genome sequences of
several C. jejuni strains (Parkhill et al., 2000; Fouts et al., 2005;
Poly et al., 2007; Hofreuter et al., 2006; Pearson et al., 2007)
has revealed that this pathogen does not encode homologs of
the glutathione biosynthesis proteins. However, glutathione is
readily available in mammalian tissues, since it is the most abun-
dant source of intracellular reactive thiol groups, and plays a key
role in detoxification of cellular free radicals, toxins, and carcin-
ogens (Meister and Anderson, 1983). In the intestinal lumen, glu-
tathione can originate from the diet, but it is also synthesized and
Figure 1. Comparative Growth of C. jejuni
81-176 and NCTC 11168 in the Presence of
Different Amino Acids
Values are the mean ±SD of three determinations
of the maximal optical density reached by C. jejuni
81-176 and NCTC 11168 after 24 hr of growth in
DMEM, supplemented with different amino acids
(20 mM) as indicated. Cultivation in BHI medium
served as control. Stars denote statistically signif-
icant (**: p < 0.0001; *: p < 0.05) growth differences
in comparison to growth in the basal medium with-
out supplemental amino acids.
secreted directly by the mucosal cells of
the gut, or can reach the intestine via se-
creted bile (Aw, 2005). Glutathione has
been shown to serve as a potential amino
acid source for E. coli and Neisseria men-
ingitidis in vitro (Takahashi et al., 2004;
Suzuki et al., 1993), and since the hydro-
lytic activity of GGT leads to the degrada-
tion of the tripeptide glutathione and the
release of glutamate (Tate and Meister, 1981), we hypothesized
that this enzyme may allow C. jejuni to utilize glutathione as an
amino acid source. Accordingly, we found that wild-typeC. jejuni
81-176 showed significantly enhanced growth in DMEM supple-
mented with glutathione (Figure 2B) in a concentration-depen-
dent manner (Figure S2). Addition of glutathione, however, did
not enhance the growth of the ggt::kan mutant (Figure 2B), which
indicates that GGT is required for glutathione utilization. Similar
results were obtained when the experiments were carried out
in rich BHI medium (Figure S3). These results are consistent
with previous observations indicating that H. pylori can degrade
glutathione in a ggt-dependent manner (Shibayama et al., 2007).
To further clarify the growth-enhancing properties of glutathi-
one, we investigated the effect of adding its degradation prod-
ucts. Supplementation with the dipeptide cysteinylglycine did
not enhance the growth of C. jejuni 81-176 (Figures 2B and
S3). However, addition of glutamate or g-glutamylcysteine en-
hanced the growth of C. jejuni 81-176 to levels equivalent to
those resulting from the addition of glutathione (Figures 2B and
S3). As expected, addition of g-glutamylcysteine did not en-
hance the growth of the C. jejuni 81-176 ggt::kan mutant, al-
though the growth of this strain was enhanced by the addition
of glutamate, which does not require GGT for its utilization (Fig-
ures 2B and S3). To investigate the possibility that the growth-
enhancing effect of glutathione and glutamine was due to the
generation of glutamate after their GGT-mediated hydrolysis,
we investigated the consequence of a mutation in peb1A
(Cj0921c) in the utilization of these nutrients. Peb1A is an aspar-
tate/glutamate-binding protein of an ABC transporter that is es-
sential for the utilization of these amino acids by C. jejuni (Leon-
Kempis Mdel et al., 2006; Pei and Blaser, 1993) and required for
virulence (Pei et al., 1998). Disruption of peb1A effectively abro-
gated the ability of C. jejuni to utilize glutathione, glutamine, and
the dipeptide g-glutamylcysteine (Figures 2B and S3). Since dis-
ruption of peb1A did not affect the GGT activity of C. jejuni
(Figure 2C), these results indicate that GGT allows the utilization426 Cell Host & Microbe 4, 425–433, November 13, 2008 ª2008 Elsevier Inc.
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C. jejuni Metabolic Diversity Enhances ColonizationFigure 2. C. jejuni g-Glutamyltranspeptidase-Dependent Utilization of Glutamine and Glutathione
(A) Expression, localization, and processing of C. jejuni 81-176 g-glutamyltranspeptidase. A diagram of the organization of C. jejuni g-glutamyltranspeptidase is
shown. Whole cell (WC) and periplasmic (PP) fractions of C. jejuni expressing FLAG epitope-tagged g-glutamyltranspeptidase examined by western blot analysis
are shown in the left panel. FLAG epitope-tagged g-glutamyltranspeptidase (GGT) or a mutant derivative lacking its putative sec-dependent secretion signal
(GGTDSP) were expressed in C. jejuni and examined by western blot analysis (right panel). Note that in the absence of the secretion signal, GGT is not efficiently
processed into the 40 and 20 kDa subunits.
(B) Ability of C. jejuni 81-176 and mutant derivatives to utilize glutamine, glutathione, and compounds derived from the activity of g-glutamyltranspeptidase.
Values are the mean ±SD of three determinations of the maximal optical density reached by wild-type C. jejuni 81-176 and its isogenic ggt::kan and peb1A::kan
mutants after 24 hr of growth in DMEM supplemented with the indicated compounds (20 mM). Stars denote statistically significant (p < 0.0001) growth differences
in comparison to growth in the basal medium without supplements.
(C) g-Glutamyltranspeptidase activity of wild-typeC. jejuni 81-176 and its isogenic ggt::kan and peb1A::kanmutants. Activity is expressed as the absorbanceA405
of released p-nitroanilide. Values represent the mean ±SD of three independent determinations. Star denotes statistically significant (p < 0.0001) difference in
comparison to the values of the wild-type strain.of glutathione, glutamine, or the dipeptide g-glutamylcysteine by
generating glutamate, which is then taken up by the Peb1A-
dependent transporter and used as a carbon source. These
results show thatC. jejuni is able to utilize glutamine and glutathi-
one in a ggt-dependent manner, and extends previous biochem-
ical observations in H. pylori indicating that this bacterium can
take up glutamate released from glutathione or glutamine by
its GGT activity (Shibayama et al., 2007). Our data also reveal
significant variability in glutathione metabolism among different
bacteria since, after GGT-dependent glutathione degradation,
E. coli and N. meningitidis utilize the released cysteine residue
rather than glutamate (Takahashi et al., 2004; Suzuki et al., 1993).
A Secreted Asparaginase Confers on C. jejuni 81-176
the Ability to Utilize Asparagine
Based on studies of the metabolism of asparagine in other bacte-
ria, it is predicted that the utilization of asparagine by C. jejuni
81-176 would require either a specific transporter for this amino
acid (Strobel et al., 1989), or a periplasmic asparaginase capable
of converting asparagine to aspartate (Singh and Rohm, 2008),
which could then be taken up by C. jejuni in a Peb1A-dependent
manner. No obvious homolog of an asparagine transporter was
detected in any of the sequenced strains of C. jejuni, although all
strains encode an L-asparaginase (annotated as Cj0029 in the ge-
nome of NCTC 11168 reference strain) with significant amino acid
sequence similarity to E. coli AnsB. Interestingly, close inspection
of the amino acid sequences of these asparaginases showed that,Cell Host &although highly related, their sequences exhibit intriguing differ-
ences. While the amino terminus of the C. jejuni 81-176 AnsB
has a canonical sec-dependent secretion signal sequence, such
a signal sequence is absent from the AnsB homolog of C. jejuni
NCTC 11168 (Figure 3A). Indeed, comparison of the nucleotide se-
quence of the 50 region of ansB in these strains revealed a striking
sequence difference. In C. jejuni 81-176, this region shows the
presence of an additional40 nucleotides adding a secretion sig-
nal to an otherwise cytoplasmic asparaginase (Figure 3A), result-
ing in a secreted form of this enzyme that allows the utilization of
asparagine by C. jejuni 81-176. Introduction of a loss-of-function
mutation in the ansB (Cj0029) homolog of C. jejuni 81-176, or ex-
changing the ansB allele with a homolog lacking the putative
sec-dependent secretion signal, abolished the ability of this strain
to utilize asparagine (Figure 3B). Conversely, the introduction of
the C. jejuni 81-176 ansB (Cj0029) allele into the C. jejuni NCTC
11168 strain allowed this strain to utilize asparagine (Figure 3C).
Furthermore, AnsB containing the putative secretion signal was
detected in the periplasmic fraction ofC. jejuni81-176, while a mu-
tant derivative expressing an allele lacking the putative secretion
signal was detected only in the cytoplasmic fraction (Figure 3D).
Moreover, utilization of asparagine by C. jejuni 81-176 required
the Peb1A-dependent aspartate transporter (Figure 3B). Taken to-
gether, these results demonstrate that the addition of a secretion
signal to an otherwise cytoplasmic asparaginase conferred to
C. jejuni 81-176 the ability to deaminate asparagine to aspartate
in the periplasm, thus allowing the utilization of asparagine asMicrobe 4, 425–433, November 13, 2008 ª2008 Elsevier Inc. 427
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(A) Comparison of the 50 nucleotide sequence of the ansB locus of C. jejuni 81-176 and NCTC 11168 strains. The putative initiation codons are indicated with
a square (for the secreted form) and with a circle (for the cytoplasmic form) of AnsB.
(B) The ability ofC. jejuni 81-176 to utilize asparagine is dependent upon secreted AnsB. Maximal optical density reached by the wild-typeC. jejuni 81-176 and the
isogenic mutants DansB, an isogenic strain expressing the ansB allele from C. jejuni NCTC11168, which lacks the secretion signal (ansBNCTC11168), DansB com-
plemented with a wild-type copy of the gene (DansB [+ansB]), and an isogenic mutant (peb1A::kan) defective in the dicarboxylic aspartate/glutamate transporter
Peb1A, after 24 hr of growth in DMEM supplemented with 20 mM asparagine. Values represent the mean ±SD of three independent determinations. Stars denote
statistically significant (p < 0.0001) growth differences in comparison to wild-type growth.
(C) Introduction of the ansB allele from C. jejuni 81-176 confers to C. jejuni NCTC 11168 the ability to utilize asparagine. Values are the mean ±SD of three de-
terminations of the maximal optical density reached by wild-type C. jejuni NCTC 11168, the isogenic mutant DansB, and a derivative expressing the ansB allele
from C. jejuni 81-176 (ansB81-176), after 24 hr of growth in DMEM supplemented with 20 mM asparagine. Star denotes statistically significant (p < 0.0001) growth
differences in comparison to the growth of wild-type NCTC 11168.
(D) Subcellular localization of AnsB. Cytoplasmic and periplasmic fractions of C. jejuni 81-176 strains expressing FLAG epitope-tagged AnsB (AnsB) or a mutant
derivative expressing an ansB allele encoding a variant without the signal sequence (AnsBDsp) were analyzed by western immunoblot with an antibody directed to
the epitope tag.a nutritional source. The presenceofa putativealternative start site
downstream from the first initiation codon in the 81-176 ansB se-
quence (Figure 3A), however, could potentially generate a cyto-
plasmic form of this enzyme, which could presumably ensure
the production of both secreted and cytoplasmic forms of this en-
zyme. The cytoplasmic form of AnsB could be involved in metab-
olizing asparagine that could be generated by the cytoplasmic
degradation of small peptides imported by specific transporters.
Clinical Isolates ofC. jejuni Exhibit SignificantMetabolic
Diversity
To investigate whether the observations made inC. jejuni 81-176
extend to other isolates, we investigated the distribution of ggt in428 Cell Host & Microbe 4, 425–433, November 13, 2008 ª2008 Elsseveral clinical isolates of C. jejuni. We were able to detect the
presence of ggt in 3 (ATCC 49943, 154.2067, and 240.0872)
out of 15 clinical isolates tested. We determined the nucleotide
sequence of ggt in these clinical isolates and found that they
can encode full-length GGT (Figure S4). Furthermore, ggt is
also present in C. jejuni 81116 (Barnes et al., 2007), whose ge-
nome sequence has recently been completed (Pearson et al.,
2007), and in the unfinished genome sequences of the C. jejuni
strains 260.94 and HB93-13, and in C. jejuni subspecies doylei
269.97. In all cases, the ggt locus is located in the vicinity of
a highly conserved ribosomal RNA gene cluster (Figure S5),
which is consistent with the hypothesis that this gene may
have been acquired by horizontal gene transfer from anotherevier Inc.
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glutamine, and found a strict correlation between the presence
of ggt and the ability to utilize this nutrient (Figures 4 and S6A).
In fact, introduction of an insertion mutation in the ggt locus of
the C. jejuni strains ATCC 49943, 154.2067, and 240.0872 abol-
ished their ability to utilize glutamine (Figure S6B). These results
indicate that theggt-mediated metabolic expansion is a common
occurrence in clinical isolates of C. jejuni. We also examined the
predicted amino acid sequence of AnsB encoded in the C. jejuni
strains whose nucleotide genome sequences are available. The
asparaginases of C. jejuni RM1221, CG8486, CF93-6, 84-25,
Figure 4. Metabolic Diversity Among
C. jejuni Isolates
Values are the mean ±SD of three determinations
of the maximal optical density reached by different
wild-type C. jejuni strains after 24 hr of growth in
DMEM supplemented with the indicated amino
acids (20 mM). The strains are grouped according
to their ggt and ansB genotypes as indicated.
and 260.94 showed no predicted N-ter-
minal secretion signal and therefore are
presumably cytoplasmic (Figure S7). In
contrast, we found sec-dependent secre-
tion signals in AnsB from C. jejuni 81116,
HB93-13, and C. jejuni subsp. doylei
269.97 as well as C. coli RM2228, C. lari
RM2100, and C. upsaliensis RM3195
(Figure S7). To expand the analysis of as-
paraginases to other C. jejuni strains, we
determined the nucleotide sequence of
ansB in several clinical isolates. In 5 out
of 15 isolates, we found asparaginases
containing a sec-dependent signal se-
quence (Figure S7). In all of these cases,
the nucleotide sequence of the 50 region
of ansB was identical to that of C. jejuni
81-176, suggesting a common origin for
the DNA segment encoding the secretion
signal (Figure S8). We also tested these
clinical isolates for their ability to utilize
asparagine, and found a strict correlation
between the presence of a sec-depen-
dent secretion signal in the predicted se-
quences of AnsB and their ability to utilize
this amino acid (Figure 4). In addition to
the difference in the ability of C. jejuni
strains to metabolize asparagine and glu-
tamine, 1 (ATCC 33251) of the 13 C. jejuni
isolates tested and C. coli ATCC 49941
were unable to grow with serine (Figure 4).
This is of interest, as C. jejuni serine me-
tabolism was shown to be important for
the effective colonization of chicken
(Velayudhan et al., 2004). Our compari-
son revealed that, of all the amino acids
tested, proline was the only one that
was able to support the growth of all
tested strains. Taken together, these results revealed an unex-
pected diversity in basic metabolic traits of different clinical iso-
lates of C. jejuni, which may affect their pathogenic potential.
C. jejuni 81-176 Exhibits Differential Nutritional
Requirements for the Efficient Colonization of Different
Tissues
We have previously shown that a ggtmutant ofC. jejuni 81-176 is
defective in its ability to colonize the intestinal tract of myd88/
mice after oral administration (Hofreuter et al., 2006), and it was
recently demonstrated that a ggt mutant of C. jejuni 81116 wasCell Host & Microbe 4, 425–433, November 13, 2008 ª2008 Elsevier Inc. 429
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C. jejuni Metabolic Diversity Enhances ColonizationFigure 5. Contribution of ggt and ansB to C. jejuni 81-176 Specific Tissue Colonization
(A) ggt is not required for efficient liver colonization by C. jejuni 81-176. Liver colonization of wild-typeC. jejuni and the ggt::kan mutant after IP administration. The
colonization of the liver was evaluated 7 weeks after coinfection with equal numbers of wild-type and ggt::kan C. jejuni strains. Each pair of black and white di-
amonds represents the CFU of wild-type and the ggt::kan mutant, respectively, recovered from the liver of an individual animal. The P values for the statistical
differences between the number of CFU of the two strains as analyzed by the Wilcoxon matched-pairs signed-rank test were not significant (p = 0. 563).
(B–E) Utilization of asparagine enhances the ability of C. jejuni 81-176 to colonize the liver but has no significant effect on its ability to colonize the intestine. Mice
were coinfected orally (B) or intraperitoneally (C–E) with equal numbers of the indicated strains. Infected mice were sacrificed 6 weeks after infection and the
number of CFU of the different strains in the indicated tissues was determined by plating in the appropriate media to distinguish the strains (note: orally infected
mice had no recoverable CFU in the liver). Each pair of black and white diamonds represents the different strains (as indicated) recovered from an individual
mouse. The P values for the statistical differences between the number of CFU of the different strains as analyzed by the Wilcoxon matched-pairs signed-ranks
test are indicated. (Note: TheP values for the statistical differences between the number of CFUs obtained in experiments shown in panels (C) and (D) combined is
p < 0.002.)defective for the intestinal colonization of chickens (Barnes et al.,
2007). We investigated the potential role of GGT in the ability of
C. jejuni to colonize the liver of myd88/ mice in competition ex-
periments, which are known to be able to resolve small differ-
ences in the colonization abilities of different bacterial strains.
Surprisingly, we found that the C. jejuni ggt mutant strain colo-
nized the liver of infected animals in a manner indistinguishable
from wild-type (Figure 5A), suggesting that glutamine and/or glu-
tathione may not be essential nutrients for C. jejuni growth in the
liver. Combined with our previous findings (Hofreuter et al.,
2006), and those of others (Barnes et al., 2007), these results re-
vealed unique nutritional requirements forC. jejuni in different tis-
sues, since glutathione and/or glutamine are important nutri-
tional sources for C. jejuni in the intestinal tract but appear to
be dispensable for its growth in the liver.
We tested whether asparagine, like glutamine and/or glutathi-
one, may also be an important nutrient during infection by com-
paring the ability of wild-type C. jejuni 81-176 and the isogenic
ansB::kan mutant to colonize mice in mixed infection experi-
ments. Five weeks after oral administration of equal numbers
of wild-type C. jejuni 81-176 and the isogenic ansB::kan mutant
strain, both strains were recovered in similar numbers from intes-
tinal tissues of colonized animals (Figure 5B). Notably, however,
the ansB::kan mutant, as well as a mutant expressing an aspar-
aginase without its secretion signal peptide (Figure S9), were sig-
nificantly defective in their ability to colonize the liver of infected
animals when administered systemically (Figure 5C). Such de-
fect was fully restored by introduction of the wild-type allele
(Figure 5D), but not by introduction of an allele lacking the secre-430 Cell Host & Microbe 4, 425–433, November 13, 2008 ª2008 Elstion signal (Figure 5E). These results indicate that, in the liver but
not in the intestine, asparagine, presumably through its metabo-
lization into asparatate, is an important nutrient for C. jejuni. The
reduced but detectable ability of the ansB::kanmutant ofC. jejuni
to colonize the liver suggests that nutrients other than aspara-
gine may be also available at this site to support limited replica-
tion of this C. jejuni strain. Together with the observations made
with the ggt mutant, these results show a remarkable specificity
in C. jejuni’s nutritional requirements to efficiently colonize differ-
ent tissues: glutathione or glutamine and the derived glutamate
in the intestine and asparagine or aspartate in the liver.
DISCUSSION
It is well established that different isolates of the same pathogen
often display significant diversity within their repertoire of viru-
lence factors (Joyce et al., 2002; Whittam and Bumbaugh,
2002), particularly in surface determinants, which are thought
to be under short-term evolutionary pressure by the host’s im-
mune response (van der Woude and Baumler, 2004; Bentley
et al., 2007). Less is known about diversity within basic metabolic
traits, which are often considered more stable attributes of bac-
terial pathogens. However, pathogens that as part of their nor-
mal ecology inhabit different environments with different avail-
able nutrients are also likely to be under strong selective
pressure to diversify and evolve their basic metabolic traits.
We have shown here that C. jejuni, a bacterial pathogen that is
capable of colonizing a diverse array of warm-blooded animals,
and persists in various environmental habitats (Young et al.,evier Inc.
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trients. This metabolic diversity translates in different capacity to
colonize different tissues. We have also presented evidence in-
dicating that such diversity is the result of the acquisition of
new genetic traits or the modification of existing ones, presum-
ably through the horizontal acquisition of genetic material.
Thus, the ability of some clinical isolates to utilize glutamine
and glutathione resulted from the acquisition of a gene encoding
a g-glutamiltranspeptidase. Furthermore, the acquisition of
a DNA segment that added a sec-dependent secretion signal
to a cytoplasmic asparaginase conferred on some clinical iso-
lates the ability to utilize asparagine.
Our results indicate that the acquisition of specific metabolic
pathways has enhanced the ability of a pathogen to colonize dif-
ferent tissues. It is unknown whether these results are significant
to human infections or to infections of other vertebrate hosts, or
whether they can be generalized to other strains of C. jejuni. In
fact, our analysis has shown that many clinical isolates of C. je-
juni do not encode GGT or a secreted form of AnsB, which sug-
gests that the ability to utilize asparagine, glutathione, and/or
glutamine is not essential for C. jejuni to cause disease in hu-
mans. Nevertheless, our findings do highlight the remarkable
specificity of the nutritional requirements for a pathogen to colo-
nize specific tissues in the animal model system utilized in these
studies. C. jejuni 81-176 was isolated from an outbreak of diar-
rheal disease in schoolchildren (Korlath et al., 1985) and an infec-
tion dose of as little as 800 organisms was sufficient to cause
illness in human volunteers (Black et al., 1988). It is possible
that the expanded ability of this C. jejuni strain to utilize amino
acids may contribute to its apparently increased infectivity. Fur-
thermore, the ability of certain C. jejuni strains to utilize a broader
range of carbon sources may confer an advantage during the
commonly observed phenomenon of infection of a single host
by multiple strains of C. jejuni (Godschalk et al., 2006; Koene
et al., 2004; Shen et al., 2001), or may be beneficial for their sur-
vival in nutrient-poor environments.
Although bacterial metabolism has been the subject of intense
study (Downs, 2006), knowledge of the nutritional requirements
of bacterial pathogens within their hosts is one of the least-
understood areas of bacterial pathogenesis (Mun˜oz-Elı´as and
McKinney, 2006). This is an extremely important area of re-
search, since understanding the in vivo nutritional requirements
of bacterial pathogens can lead to the development of novel
therapeutic strategies (Brown et al., 2008). The availability of
the genome sequences of most bacterial pathogens has allowed
the in silico reconstruction of their metabolic pathways (Marais
et al., 1999; Doig et al., 1999; Bono et al., 1998; Feist and Pals-
son, 2008). However, this information, combined with traditional
studies of bacterial physiology in artificial cultures, has signifi-
cant limitations since the metabolism of pathogenic bacteria
during infection can differ profoundly from their metabolism
in vitro (Mun˜oz-Elı´as and McKinney, 2006). Only the understand-
ing of the complex in vivo nutritional requirements of bacterial
pathogens can lead to the effective design of new antimicrobials.
Targeting metabolic pathways as an antimicrobial strategy could
be challenging in the case of bacterial pathogens, such as Sal-
monella enterica, with complex and redundant metabolic path-
ways (Becker et al., 2006). However, in the case of nonsacchar-
olytic pathogens with more restricted metabolic capabilities,Cell Hostsuch as Campylobacter jejuni, this strategy offers more promis-
ing prospects. The findings reported here further emphasize the
need for the study of metabolic requirements in the context of in-
fection, and dramatically showcase a set of adaptations sculp-
ted by evolutionary forces to maximize the fitness of a pathogen.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, and Culture Conditions
The wild-typeC. jejuni strains 81-176 and RM1221 were obtained from Patricia
Guerry (Naval Medical Research Center) and Robert E. Mandrell (Agricultural
Research Service, US Department of Agriculture; Albany, NY), respectively.
Other clinical isolates from infected patients were obtained from Christine Gi-
nocchio (North Shore-Long Island Jewish Health System) or from ATCC (Man-
assas, VA). Bacterial strains were grown routinely on brucella agar or tryptic
soy agar plates supplemented with 5% defibrinated sheep blood in a 10%
CO2 atmosphere at 37
C. Selective plates were supplemented with chloram-
phenicol (7.5 mg/liter) or kanamycin (50 mg/liter). Brain heart infusion (BHI) me-
dium was used to grow C. jejuni in liquid culture. Alternatively, C. jejuni strains
were grown in the defined medium DMEM (GIBCO; catalogue number 11965)
supplemented with Fe2+ in the form of Iron(II)-ascorbate (Sigma; catalogue
number AO207). Specific amino acids (Sigma) for supplementation of the
DMEM were used in concentrations of 20 mM. For growth assays,C. jejuni cul-
tures were adjusted to an OD600 of 0.1–0.2 in 3 ml of the appropriate liquid me-
dium and grown under an atmosphere of 10% CO2 in a rotating wheel (50 rpm).
For larger culture volumes, C. jejuni was grown in 125–250 ml Erlenmeyer
flasks in 10% CO2 atmosphere at 37
C with orbital shaking (200 rpm). Bacterial
growth was monitored by measuring the optical density of the cultures at
600 nm (OD600) with a spectrophotometer (Spectronic 20, Genesys). Statistical
analysis of the results was carried out by Student’s t test.
Construction of C. jejuni Mutants
The ggt::kan mutant derivatives of the clinical isolates C. jejuni ATCC 49943,
154.2067, and 240.0872 were generated by transforming into these strains
chromosomal DNA isolated from the previously described ggt::kan mutant de-
rivative ofC. jejuni 81-176 (Hofreuter et al., 2006), followed by selection on bru-
cella agar plates supplemented with kanamycin. C. jejuni 81-176 peb1A::kan
and ansB::kan (Cj0029) derivatives were constructed by allelic exchange fol-
lowing the standard procedures previously described (Hofreuter et al.,
2006). Strains of C. jejuni expressing a FLAG epitope-tagged GGT or AnsB
were generated by standard PCR, recombinant DNA, and allelic exchange
procedures using a chloramphenicol resistance marker (lacking transcription
terminator) placed immediately downstream from the tag for selection.
Subcellular Fractionation of C. jejuni
Subcellular fractionation of C. jejuni was carried out as previously described
(Leon-Kempis Mdel et al., 2006).
GGT Activity
GGT activity was assayed as previously described (McGovern et al., 2001).
Statistical analysis of the results was carried out by Student’s t test.
C. jejuni Mouse Infections
The mouse model forC. jejuni infection has been previously described (Watson
et al., 2007). Age-matched (6–8 weeks) myd88/ nramp1/ male mice were
infected orally or intraperitoneally with equal numbers (109 or 107 CFU for oral
or intraperitoneal [IP] infections, respectively) of the different C. jejuni strains.
At the indicated times, animals were sacrificed, intestine and liver were
removed and homogenized, and the bacterial loads in different tissues were
determined by serial plating on brucella agar plates supplemented with Cam-
pylobacter selective medium (Oxoid), with or without the appropriate antibi-
otics (kanamycin, 50 mg ml1 or chloramphenicol, 7.5 mg ml1) to distinguish
between wild-type and mutant strains. For IP coinfection of mice with the
C. jejuni 81-176 wild-type strain and its ggtmutant, one experiment with six an-
imals was performed (Figure 5A). Two independent experiments with five
animals each were done for the oral coinfection of the wild-type strain and
the DansB mutant (Figure 5B), and two independent experiments with three& Microbe 4, 425–433, November 13, 2008 ª2008 Elsevier Inc. 431
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strain and the DansB mutant (Figure 5C). For coinfection experiments of the
DansB mutant and its derivative complemented with a wild-type copy of
ansB, two independent experiments were performed with four animals each
(Figure 5D). Coinfection experiments with the DansB mutant and its deriva-
tive-encoding AnsB lacking the secretion signal were conducted in two sepa-
rate infections with five and six animals (Figure 5E). Statistical analysis of the
results was carried out with the Wilcoxon matched-pairs signed-ranks test.
Sequence Analysis and Strain Comparison
Predictions of open reading frames (ORFs) for the genome sequences avail-
able in the GenBank were performed with ARTEMIS (http://www.sanger.ac.
uk/Software/Artemis), with a cutoff of 100 bp, and BLASTX (http://www.
ncbi.nlm.nih.gov/BLAST). Homology searches were performed with BLASTP
and BLASTN (http://www.ncbi.nlm.nih.gov/BLAST). CampyDB was used for
specific comparison of the published genome sequences of Campylobacter
(Chaudhuri and Pallen, 2006) (http://campy.bham.ac.uk). ClustalW (http://
www.ebi.ac.uk/clustalw) was used for multiple DNA and protein sequence
alignments.
ACCESSION NUMBERS
Sequences of the ggt locus from C. jejuni isolates described in this study have
been deposited in GenBank with the accession numbers FJ234213, FJ234214
and FJ234215 for the strains C. jejuni 154.2067, 240.0872, and ATCC 49943,
respectively. Sequences of the different C. jejuni ansB loci described in these
studies have been deposited in GenBank with the following accession num-
bers: FJ234222 (ATCC 33251), FJ234224 (152.0699), FJ234225 (153.1039),
FJ234227 (234.1072), FJ234219 (ATCC 33253), FJ234220 (ATCC 29428),
FJ234216 (ATCC 33250), FJ234217 (ATCC 33291), FJ234228 (M.D. Blood),
FJ234223 (W6984), FJ234221 (ATCC 33560), FJ234218 (ATCC 49943),
FJ234226 (154.2067), FJ234229 (240.0872). The sequence of the ansB locus
from Campylobacter coli ATCC 49941 has been deposited in GenBank with
the accession number FJ234230.
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